Physician profile
Blane T Shatkin
NPI 1215955653
$2,073.79
in general payments reported to CMS, 2019-2025
9 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Undersea and Hyperbaric Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $44.71 · 2021: $274 · 2022: $298 · 2023: $76.18 · 2024: $394 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491 · Long Term Medical Supply Or Device Loan: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.60 |
| Long Term Medical Supply Or Device Loan | $120.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $573.54 | 2019-2025 | Apligraf |
| Integra Lifesciences Corporation | $525.66 | 2019-2024 | Integra |
| Smith+Nephew, INC. | $232.22 | 2019-2022 | |
| Convatec INC. | $214.97 | 2019 | |
| Avita Medical Americas, LLC | $148.33 | 2024 | |
| Solventum Corporation | $125.06 | 2024 | V.A.C. Veraflo |
| Kci USA, INC. | $98.17 | 2022 | |
| Eagle Pharmaceuticals, INC. | $79.66 | 2019 | |
| Dilon Technologies, INC. | $76.18 | 2023 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blane Shatkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.